The Bright and Dark Side of Nrf2 for Tissue Protection
Monday April 23, 2018
9:30 am
-
12:00 pm
Eastern Time (ET)
Room 15B
TOX
Chair :
Qin Chen
University of Arizona
Nrf2 gene encodes a transcription factor known for regulating antioxidant and detoxification genes. Genome wide studies have revealed Nrf2 control over 600 genes, including genes for anabolic metabolism, cell proliferation and extracellular matrix remodeling. Keap1 mediated Nrf2 ubiquitination can be hijacked by small molecules from natural products for inducing Nrf2 and tissue protection. Keap1 independent mechanisms have been recently reported for Nrf2 activation and tissue protection. Mutation or hyperactivation consists the dark side of Nrf2 due to its participation in cancer cell proliferation and resistance to treatment. The symposium presents the latest findings from the experts in Nrf2 research.
Speakers
Donna Zhang
- University of Arizona
Canonical and Non-canonical Pathways of Nrf2 Activation
Jeffrey Johnson
- University of Wisconsin
Nrf2 as a Therapeutic Target for Treatment of Neurodegenerative Diseases
Thomas Kensler
- University of Pittsburgh
Keap 1 Independent Mechanism of Nrf2 Protection Against Liver Injury
Lu Cai
- University of Louisville
The Interplay of MicroRNAs and Nrf2 Inducers in Diabetic Complications
Min-Kyun Song
- The Catholic University of Korea
NFE2L2 (Nrf2) Attenuates Tgf-β1 Signaling by Elevation of Smad7 in Mouse Mesangial MES-13 Cells